스페인의 병원 용품 시장 : 시장 점유율 분석, 산업 동향, 통계, 성장 예측(2025-2030년)

The Spain hospital supplies market size reached USD 2.84 billion in 2025 and is forecast to climb to USD 3.78 billion by 2030, translating into a 5.90% CAGR over the period.

Spain's solid public-sector foundation, together with targeted Recovery and Resilience Facility investments, underpins this consistent trajectory even as other European healthcare systems show greater volatility. Rising life expectancy, a sharply expanding population segment aged 90 years and above, and stricter infection-prevention standards reinforce equipment renewal cycles, while digital procurement mandates accelerate order fulfilment. Global multinationals and domestic specialists compete on value, compliance support and rapid logistics, creating a balanced yet dynamic competitive field. Continued EU harmonisation through the Medical Device Regulation (MDR) and the European Health Data Space is driving both standardisation benefits and added compliance costs.

Spain Hospital Supplies Market Trends and Insights

Rising Incidence of Infectious & Chronic Diseases

Surveillance data show that 7.1% of EU hospital patients experience healthcare-associated infections, with respiratory conditions at the forefront. Spain's universal health system guarantees treatment for those cases, translating into predictable bulk procurement of diagnostic kits, sterile consumables and respiratory support devices. The 2024 Universal Health-Care Bill extended coverage to temporary residents and asylum seekers, widening the beneficiary pool. As hospitals integrate chronic-care and infection-control pathways, suppliers benefit from bundled tenders that combine disposables with automated sterilisation units, while analytics-enabled devices support longitudinal disease management across inpatient and outpatient settings.

Growing Awareness of Hospital-Acquired Infections

An estimated 3.5 million HAI cases and more than 90,000 related deaths occur annually across the EU, up to half of which are preventable through stronger infection-control practices. Spanish hospitals respond by favouring CE-marked single-use devices and traceable sterilisation systems that comply with MDR post-market surveillance rules. Tender specifications increasingly reference antimicrobial surfaces and closed-system drug-transfer solutions, rewarding vendors that certify ISO-compliant clean-room manufacturing. As procurement teams quantify the cost of outbreak containment versus up-front product premiums, infection-control portfolios gain strategic weight.

Stringent Regulatory Framework

The MDR requires legacy devices to align with updated quality-management standards by May 2024, while transitional grace periods run no later than December 2028. Spain's AEMPS further obliges in-country registration of all medical devices and mandates supply-interruption notifications under Regulation (EU) 2024/1860. Smaller manufacturers face high compliance costs for risk-based classification, unique-device identification labelling and periodic safety-update reports. Consequently, distributors consolidate their portfolios around MDR-approved products, potentially narrowing brand choice and lengthening market-entry timelines for innovative SMEs.

Other drivers and restraints analyzed in the detailed report include:

1. Rapidly Ageing Spanish Population
2. Digitalised Public Procurement Accelerating Fulfilment
3. Shift Toward Home-Care Services

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Disposable hospital supplies accounted for 45.51% of Spain hospital supplies market share in 2024, reflecting persistent emphasis on single-use safety protocols. Sterilisation and disinfection equipment, posting a 7.65% CAGR to 2030, benefits from rising HAI awareness and MDR traceability rules. The Spain hospital supplies market size for sterilisation systems is projected to expand steadily as hospitals upgrade to low-temperature and hydrogen-peroxide units that protect heat-sensitive devices.

Operating-room equipment and diagnostic instruments continue to receive budget allocations tied to Recovery Plan grants, while syringe and needle specifications evolve following ophthalmology safety alerts on silicone-oil droplets. Suppliers of CE-marked micro-volume syringes with zero residual volume capture niche but high-value orders.

The Spain Hospital Supplies Market is Segmented by Product (Patient Examination Devices, Operating Room Equipment, Mobility Aids and Transportation Equipment, Sterilisation & Disinfection Equipment, and More), End-User Facility (Public Hospitals, Private Hospitals, and More), Distribution Channel (Direct Public Tenders, Online B2B Platforms, and More). The Market Forecasts are Provided in Terms of Value (USD).

List of Companies Covered in this Report:

1. Solventum Corporation
2. B. Braun
3. Baxter
4. Beckton Dickinson
5. Cardinal Health
6. Medtronic
7. GE HealthCare Technologies Inc.
8. Thermo Fisher Scientific
9. Johnson & Johnson (Ethicon, DePuy)
10. Fresenius
11. Grifols
12. Werfen
13. Palex Medical
14. Izasa Medical
15. Smiths Group
16. Stryker
17. Dragerwerk
18. Siemens Healthineers
19. Olympus
20. Terumo

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Incidence Of Infectious & Chronic Diseases
  • 4.2.2 Growing Awareness Of Hospital-Acquired Infections
  • 4.2.3 Rapidly Ageing Spanish Population
  • 4.2.4 Digitalised Public Procurement Accelerating Fulfilment
  • 4.2.5 EU RRF Funds Modernising Hospital Infrastructure
  • 4.2.6 Domestic Single-Use Plastics Capacity Expansions
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Framework
  • 4.3.2 Shift Toward Home-Care Services
  • 4.3.3 EU Plastic-Tax Driven Input-Cost Volatility
  • 4.3.4 Fragmented Regional-Budget Procurement Cycles
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Porter's Five Forces
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Bargaining Power of Suppliers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Patient Examination Devices
  • 5.1.2 Operating-Room Equipment
  • 5.1.3 Mobility Aids & Transport Equipment
  • 5.1.4 Sterilisation & Disinfection Equipment
  • 5.1.5 Disposable Hospital Supplies
  • 5.1.6 Syringes & Needles
  • 5.1.7 Other Products
• 5.2 By End-User Facility
  • 5.2.1 Public Hospitals
  • 5.2.2 Private Hospitals
  • 5.2.3 Specialised Clinics
  • 5.2.4 Diagnostic & Imaging Centres
• 5.3 By Distribution Channel
  • 5.3.1 Direct Public Tenders
  • 5.3.2 Group-Purchasing Organisations (GPOs)
  • 5.3.3 Online B2B Platforms
  • 5.3.4 Retail & Community Pharmacies

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Solventum Corporation
  • 6.3.2 B. Braun SE
  • 6.3.3 Baxter International Inc.
  • 6.3.4 Becton, Dickinson and Company
  • 6.3.5 Cardinal Health Inc.
  • 6.3.6 Medtronic plc
  • 6.3.7 GE HealthCare Technologies Inc.
  • 6.3.8 Thermo Fisher Scientific Inc.
  • 6.3.9 Johnson & Johnson (Ethicon, DePuy)
  • 6.3.10 Fresenius Medical Care AG & Co. KGaA
  • 6.3.11 Grifols S.A.
  • 6.3.12 Werfen
  • 6.3.13 Palex Medical
  • 6.3.14 Izasa Medical
  • 6.3.15 Smith & Nephew plc
  • 6.3.16 Stryker Corporation
  • 6.3.17 Dragerwerk AG & Co. KGaA
  • 6.3.18 Siemens Healthineers AG
  • 6.3.19 Olympus Corporation
  • 6.3.20 Terumo Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment